FDA approves first therapy for symptomatic dermographism
-
By
-
Teraya Smith
-
October 7, 2026
-
2 min
By
Teraya Smith
October 7, 2026
A randomized clinical trial found that a team-based connected health model achieved equivalent improvements in atopic dermatitis severity and symptoms compared with conventional in-person care over 12 months.
July 9, 2026
First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.
August 31, 2026